ARCHIVES

Cancer Research Faces A “Strategic Inflection,” NCI Director Says

This article is from The Cancer Letter archive.

Vol. 28 No. 16 | April 19, 2002

Download PDF Visit The Full Archive

Related Articles

Pursuit Of Truth Was Not An NIH Objective In Gallo Case, Dingell Staff Report Says

January 6, 1995

In Brief: Nabel To Direct Vaccine Research Center; Former NIH Director Robert Marston Is Dead

March 19, 1999

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

June 11, 2014

Includes 8-page April 2002 Business & Regulatory Report.

May 3, 2002

Sweden Approves Photofrin For Palliation Of Two Cancers.

July 28, 2000

Study Finds Up To 12 Percent Of Specimens Misdiagnosed

October 28, 2005